Long-Term Survival and Late Events After Allogeneic Stem-Cell Transplantation with Reduced-Intensity Conditioning (RIC) for AML and Mds; Comparable Results with Myeloablative Conditioning

被引：0
|
作者：
Shimoni, Avichai [1 ]
Rand, Avitat [1 ]
Shem-Tov, Noga [1 ]
Hardan, Izhar [1 ]
Volchek, Yulia [1 ]
Maayaan, Hannah [1 ]
Yerushalmi, Ronit [1 ]
Nagler, Arnon [1 ]
机构：
[1] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, IL-52621 Tel Hashomer, Israel
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：214 / 215
页数：2
相关论文
共 50 条
  • [1] Long-term survival and late events after allogeneic stem cell transplantation for acute leukaemia and MDS: comparable results with myeloablative and reduced-intensity conditioning
    Shimoni, A.
    Rand, A.
    Shem-Tov, N.
    Hardan, I.
    Volchek, Y.
    Maayaan, H.
    Yerushalmi, R.
    Nagler, A.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S59 - S59
  • [2] Long-Term Survival and Late Events after Allogeneic Stem-Cell Transplantation (SCT) for AML with Myeloablative (MAC) Compared to Reduced-Intensity Conditioning (RIC). A report on behalf of the ALWP of EBMT
    Shimoni, A.
    Labopin, M.
    Savani, B.
    Volin, L.
    Ehninger, G.
    Kuball, J.
    Bunjes, D.
    Schaap, N.
    Milpied, N.
    Bacigalupo, A.
    Veelken, J. H.
    Sierra, J.
    Ganser, A.
    Niederwieser, D.
    Mohty, M.
    Nagler, A.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S13 - S13
  • [3] Long-Term Survival and Quality of Life Assessment After Allogeneic Stem-Cell Transplantation; Comparable Results Following Myeloablative and Reduced-Intensity Conditioning
    Shimoni, Avichai
    Tallis, Eran
    Shem-Tov, Noga
    Volchek, Yulia
    Yerushalmi, Ronit
    Nagler, Arnon
    [J]. BLOOD, 2011, 118 (21) : 1749 - 1749
  • [4] LONG-TERM SURVIVAL AND QUALITY OF LIFE (QOL) ASSESSMENT AFTER ALLOGENEIC STEM-CELL TRANSPLANTATION (SCT) FOR ACUTE LEUKEMIA AND MDS; COMPARABLE RESULTS WITH MYELOABLATIVE AND REDUCED-INTENSITY CONDITIONING
    Shimoni, A.
    Talus, E.
    Rand, A.
    Shem-Tov, N.
    Volchek, Y.
    Yerushalmi, R.
    Nagler, A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S177 - S177
  • [5] Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up
    Shimoni, A.
    Hardan, I.
    Shem-Tov, N.
    Yerushalmi, R.
    Nagler, A.
    [J]. LEUKEMIA, 2010, 24 (05) : 1050 - 1052
  • [6] Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up
    A Shimoni
    I Hardan
    N Shem-Tov
    R Yerushalmi
    A Nagler
    [J]. Leukemia, 2010, 24 : 1050 - 1052
  • [7] Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity
    A Shimoni
    I Hardan
    N Shem-Tov
    M Yeshurun
    R Yerushalmi
    A Avigdor
    I Ben-Bassat
    A Nagler
    [J]. Leukemia, 2006, 20 : 322 - 328
  • [8] Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity
    Shimoni, A
    Hardan, I
    Shem-Tov, N
    Yeshurun, M
    Yerushalmi, R
    Avigdor, A
    Ben-Bassat, I
    Nagler, A
    [J]. LEUKEMIA, 2006, 20 (02) : 322 - 328
  • [9] Long-term survival and quality of life assessment after allogeneic stem cell transplantation for haematological malignancies; comparable results following myeloablative and reduced-intensity conditioning
    Shimoni, A.
    Tallis, E.
    Shem-Tov, N.
    Volchek, Y.
    Yerushalmi, R.
    Nagler, A.
    [J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S51 - S52
  • [10] LONG-TERM OUTCOME (BEYOND 10 YEARS) AFTER ALLOGENEIC STEM-CELL TRANSPLANTATION WITH REDUCED-INTENSITY COMPARED TO MYELOABLATIVE CONDITIONING; SIMILAR SURVIVAL BUT DIFFERENT PATTERN OF LATE EVENTS
    Shimoni, A.
    Yerushalmi, R.
    Shem-Tov, N.
    Volchek, Y.
    Nagler, A.
    [J]. HAEMATOLOGICA, 2013, 98 : 371 - 371
12345